Clinical Trial Update: IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

View source ↗

Summary

Immune checkpoint inhibitor–related gonadal toxicity in premenopausal women and men with melanoma is described. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Melanoma (Skin Cancer) | Status: RECRUITING